🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

BMO Capital sees upside in Bath & Body Works stock despite mixed guidance

EditorEmilio Ghigini
Published 28/08/2024, 15:22
BBWI
-

On Wednesday, BMO Capital maintained its Outperform rating on Bath & Body Works Inc. (NYSE:BBWI) stock with a steady price target of $52.00.

Following the company's latest earnings report, the firm acknowledged a revenue shortfall but highlighted a slight earnings per share (EPS) outperformance, attributed to a notably improved gross margin (GM).

The management team at Bath & Body Works adjusted their guidance, projecting the third quarter's revenue at the higher end of expectations, while forecasting EPS just below, which the analyst anticipates may be a conservative estimate. Additionally, the full-year EPS forecast was revised slightly above the consensus, indicating a cautious approach.

The financial update from Bath & Body Works revealed mixed results, with sales not meeting the anticipated targets but earnings showing resilience. This was partly due to a stronger gross margin, which helped to offset some of the revenue weaknesses.

The company's forward-looking statements suggest a potential for revenue growth in the third quarter, although earnings projections are set with a conservative tone, likely reflecting a strategic stance by the management.

In response to the revised full-year earnings guidance, which now sits just above the consensus, the analyst from BMO Capital expressed an understanding that while lowering forecasts is not typically a positive sign, investor expectations had largely anticipated this move.

Some investors had even braced for a more significant downturn, which the analyst believes has led to an appealing valuation for the company's stock.

The analyst's commentary included a perspective that investors had largely anticipated the need for adjustments in the company's financial outlook.

There was a sentiment among market participants that the revisions, while not ideal, were expected, and some had even prepared for more drastic changes. This anticipation, according to the analyst, has contributed to an attractive valuation for Bath & Body Works shares.

Looking ahead, Bath & Body Works' management and stakeholders will likely focus on the upcoming earnings call for further details and insights into the company's performance and strategic direction.

The analyst's comments suggest that the call may provide additional context and clarification on the company's future expectations and operational strategies.

In other recent news, Bath & Body Works has reported a series of financial developments. The company's first-quarter earnings exceeded expectations, with earnings per diluted share rising to $0.38, a 15% increase from the previous year. Net sales reached $1.4 billion, despite a marginal decline of 0.9%.

Telsey Advisory Group, BMO Capital, and TD Cowen maintained their positive ratings on Bath & Body Works, highlighting the company's robust performance and successful emphasis on new products.

However, Citi and Piper Sandler revised down their price targets for the company, reflecting concerns over the company's revenue and profit margins. In contrast, Bath & Body Works has made strides in its operations, as evidenced by improved margins and the success of new product categories.

In corporate governance, Bath & Body Works made amendments to its bylaws and held its annual stockholder meeting, electing ten directors to the company's board and ratifying Ernst & Young LLP as the independent registered public accounting firm for the fiscal year 2024. These are the latest updates in the company's recent developments.

InvestingPro Insights

Bath & Body Works Inc. (NYSE:BBWI) is currently navigating the market with some notable financial metrics and strategic positions that investors should consider. With a market capitalization of $7.75 billion and a compelling price-to-earnings (P/E) ratio of 8.91, the company stands out for its value proposition. This P/E ratio is particularly interesting when paired with the company’s near-term earnings growth potential, suggesting that the stock could be trading at a discount to its future earnings capacity.

The company's commitment to shareholder returns is further evidenced by its impressive track record of maintaining dividend payments for 52 consecutive years, a testament to its financial discipline and operational stability. Additionally, the dividend yield stands at 2.3%, which can be an attractive point for income-focused investors.

InvestingPro Tips highlight that despite recent price volatility, with a significant drop over the last three months, analysts are optimistic about the company's profitability in the upcoming year. This aligns with the management's guidance and the analyst’s expectations of a conservative yet potentially upward-trending earnings forecast. Investors looking for more insights will find an additional 9 InvestingPro Tips on Bath & Body Works, providing a comprehensive analysis that could guide investment decisions.

For those considering Bath & Body Works as an investment opportunity, these insights, along with the additional tips available on InvestingPro, can offer a deeper understanding of the company's financial health and future prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.